DOO

Analyst Note: BRP Inc. (DOO)

Date: 2026-06-13 Current Price: $59.52

1. Structural Readiness

State: Context-Only (Forming Coil)

Technical Configuration:

• Conservative Entry: Not yet defined (awaiting confirmed breakout).
• Aggressive/Pre-Breakout Entry: N/A (Current price is in the consolidation zone).
• Breakout Level: Not yet triggered.
• Current Price: $59.52.
• Extension: Not applicable (price is within the consolidation range, not extended above the breakout level).
• ATR Context: Current ATR is 3.9% (Productive). This sits within the historical "sweet spot" (4–6% range is optimal, 3.9% is slightly below but indicates healthy, non-extreme volatility suitable for position sizing).

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None named at this date.

This is a tactical, setup-led name. There is no named macro or secular thesis attached to BRP (DOO) as of 2026-06-13. The investment case must be judged strictly on the quality of the technical setup (the forming coil) and the underlying business fundamentals (revenue growth, margin expansion, and inventory normalization) rather than a broader thematic tailwind.

3. Business Overview

Company Profile: BRP Inc. is a leading international enterprise focused on the conceptualization, manufacturing, and global distribution of powersports vehicles and marine leisure products. The company operates two primary divisions:

• Powersports: Features a broad array of recreational vehicles (ORVs) under brands including Ski-Doo, Lynx, and Can-Am.
• Marine: Dedicated to water-based recreational activities, providing boats, pontoons, and outboard engines under brands like Sea-Doo, Alumacraft, and Manitou.
• Additional Segments: The company supplies OEM engines (Rotax) for karts, recreational aircraft, and jet boats, alongside a wide selection of parts, accessories, apparel (PA&A), and related services.

Fundamental Evidence (as of 2026-06-13):

• Financial Guidance (Source: Earnings Transcript, 2025-12-04): Management has set a clear trajectory. They expect to deliver $8.3 billion of revenue, $1.1 billion of normalized EBITDA, and $5.00 of normalized EPS for the fiscal year ending 2025.
• Long-Term Objectives: Management introduced a financial objective of $9.5 billion in revenue and $8.00 in normalized EPS by the end of fiscal 2028.
• Recent Performance: In the most recent quarter reported (Q3 2025), revenue was up 22% to $1.3 billion, driven by higher ORV shipments following new product launches. Management noted this was their "strongest third quarter ever at retail for side-by-side."
• Operational Status: Management stated that the "rightsizing of our network inventory is largely complete," suggesting the supply chain normalization phase is concluding.
• Forward Outlook: Management expects to carry this momentum into fiscal 2027, positioning the company to deliver double-digit normalized EPS growth.
• Valuation Context (Source: Financial Spine, 2026-06-12): Forward consensus EPS is estimated at $3.69 for FY1 and $2.27 for FY2.

4. Archetype and Conviction

Archetype: Deep Value Recovery Rationale: The name fits the "Deep Value Recovery" archetype because the business has navigated a period of inventory correction (now "largely complete") and is transitioning into a phase of accelerated growth (22% revenue growth, double-digit EPS growth expected). The market appears to be re-rating the stock based on the successful execution of the "rightsizing" strategy and the launch of new products.

Conviction Stack:

• Thesis Strength: Moderate. The thesis is tactical and relies on the successful execution of management's guidance rather than a unique macro tailwind.
• Evidence Quality: High. The evidence base is robust, citing specific earnings transcripts with clear revenue/EBITDA/EPS targets and recent quarter performance.
• Structural Quality: Moderate to High. The "Forming" coil indicates a healthy consolidation pattern. The current ATR of 3.9% suggests the stock is not in a state of extreme volatility (which often precedes severe losses) nor is it stagnant.
• Setup Readiness: Partial. The setup is "Forming," meaning the structure is ready, but the catalyst (breakout) has not yet occurred.
• Rerating Potential: High. The gap between the current consensus EPS ($3.69) and management's 2025 normalized EPS target ($5.00) suggests significant upside potential if management guidance is met or exceeded.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Guidance Raise: Any upward revision to the $9.5B revenue or $8 EPS targets for 2028 would significantly boost conviction.
• Inventory Turnover Confirmation: Further data confirming that the "rightsizing" has led to improved inventory turnover ratios in the next quarterly report.

What Would Invalidate the Case:

• Fundamental Miss: A significant miss on the $8.3B revenue or $1.1B EBITDA targets for the current fiscal year, or a failure to deliver the expected double-digit EPS growth in fiscal 2027.
• Inventory Re-accumulation: Evidence that inventory rightsizing is incomplete or that inventory levels are rising again, contradicting management's statement.

Gaps in Evidence:

• Breakout Level: The specific price point required to trigger the breakout is not defined.
• Sector/Industry Classification: The specific sector and industry labels are missing from the provided data, though the business description is clear.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: Medium Key evidence: Management guidance of $5.00 normalized EPS for 2025 vs. consensus of $3.69; 22% revenue growth in Q3 driven by new product launches; inventory rightsizing largely complete. Key risks: Technical setup remains "forming" and requires a confirmed breakout; potential for inventory re-accumulation if demand softens; lack of named secular thesis to provide macro tailwinds. Sizing hint: Position size should reflect the "forming" nature of the setup; smaller than a confirmed breakout position until the breakout level is breached. Expected path: Management expectations suggest continued momentum into fiscal 2027 with double-digit EPS growth; structural implication is a re-rating as the market prices in the achievement of the $9.5B revenue target. Expected horizon: 6 to 12 months for the thesis to fully play out as guidance is delivered.